Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Anna Cäcilia InghamKatrine KielsenHanne MordhorstMarianne IfversenFrank M AarestrupKlaus Gottlob MüllerSünje Johanna PampPublished in: Microbiome (2021)
This study reveals for the first time bacteria in the mouth and nose that may predict aGvHD. Monitoring of the microbiota at different body sites in HSCT patients and particularly through involvement of samples prior to transplantation may be of prognostic value and could assist in guiding personalized treatment strategies. The identification of distinct bacteria that have a potential to predict post-transplant aGvHD might provide opportunities for an improved preventive clinical management, including a modulation of microbiomes. The host-microbiota associations shared between several body sites might also support an implementation of more feasible oral and nasal swab sampling-based analyses. Altogether, the findings suggest that the microbiota and host factors together could provide actionable information to guiding precision medicine. Video Abstract.
Keyphrases
- stem cell transplantation
- high dose
- end stage renal disease
- newly diagnosed
- ejection fraction
- healthcare
- liver failure
- chronic kidney disease
- primary care
- peritoneal dialysis
- bone marrow
- hematopoietic stem cell
- low dose
- stem cells
- intensive care unit
- cell therapy
- drug induced
- respiratory failure
- bioinformatics analysis